Step 1 topics → Hematology and Oncology → Hereditary Spherocytosis

Hereditary Spherocytosis

USMLE Step 1 trap: Misclassifies HS as microcytic because spherocytes look small, missing that MCV is normal and MCHC is elevated. HS causes normocytic anemia; spherocytes appear small visually but MCV is normal, while MCHC is characteristically elevated.

Hereditary spherocytosis (HS) is a genetic disorder of the red blood cell cytoskeleton — most commonly due to defects in ankyrin, spectrin, or band 3 protein — that causes RBCs to lose their biconcave shape and become rigid spheres on USMLE Step 1. These spherocytes can't deform through the splenic sinusoids and get trapped and destroyed there, making this an extravascular hemolytic anemia. The biggest trap: students see small spherocytes and jump to microcytic anemia, but MCV is normal in HS — what's elevated is MCHC, because hemoglobin is packed into a smaller surface area. USMLE Step 1 loves this condition because it sits at the intersection of biochemistry (cytoskeletal proteins), pathophysiology (splenic trapping), and clinical diagnosis (smear + labs + confirmatory testing).

The exam tests HS from multiple angles: pure recall of the defective proteins, application of lab patterns to differentiate HS from other hemolytic anemias, and clinical vignette interpretation where you need to recognize the specific combination of findings that point to HS over competitors like G6PD deficiency or autoimmune hemolytic anemia (AIHA). The biggest traps are misclassifying the anemia type (students see small spherocytes and jump to microcytic) and confusing HS with AIHA because both show spherocytes on smear. Knowing what differentiates them is exactly what Step 1 will demand.

What makes HS particularly high-yield is that almost every feature is testable in isolation or in combination: the elevated MCHC, the negative Coombs, the osmotic fragility test, the eosin-5-maleimide (EMA) binding assay, and the post-splenectomy infection risk. Students who understand the underlying cytoskeletal defect can reason through any vignette rather than just memorizing a list — and that's the difference between a 50% and a 90% on these questions.

From real student decks
68%have cards covering this topic
54%have mature cards

Common misconceptions

Common mistake
Wrong: Hereditary spherocytosis causes microcytic anemia because spherocytes appear small on smear.
Right: HS causes normocytic anemia; spherocytes appear small visually but MCV is normal, while MCHC is characteristically elevated.
Spherocytes look small on smear because they've lost the membrane surface area that creates the normal biconcave disc shape — but MCV measures volume, not diameter, and the volume is preserved. This is why MCV is normal in HS. What IS elevated is MCHC: the same amount of hemoglobin is packed into a smaller surface area, increasing the concentration. On USMLE Step 1, elevated MCHC in the setting of hemolytic anemia is a classic flag for HS — not microcytic anemia.
Common mistake
Wrong: The Coombs test is positive in hereditary spherocytosis because spherocytes also appear in autoimmune hemolytic anemia.
Right: The direct Coombs test is negative in HS because hemolysis is due to a cytoskeletal defect, not antibody-mediated destruction.
Both HS and AIHA produce spherocytes, but through completely different mechanisms — this is the core distinction the exam exploits. In AIHA, antibodies coat the RBC surface, causing partial phagocytosis by splenic macrophages that rounds off the cell; the direct Coombs test detects these antibodies and is positive. In HS, there are no antibodies — the problem is an intrinsic cytoskeletal defect that makes the membrane fragile and unstable. No antibodies means a negative Coombs. If you see spherocytes + positive Coombs, think AIHA; if you see spherocytes + negative Coombs, think HS.
Common mistake
Gap: Misses that splenectomy for HS requires post-splenectomy vaccination against encapsulated organisms
Splenectomy in HS corrects hemolysis but increases lifelong risk of infection with encapsulated organisms, requiring vaccination against S. pneumoniae, H. influenzae, and N. meningitidis.
Splenectomy is highly effective in HS — it removes the site of destruction and essentially cures the hemolysis — but the spleen is a critical part of immune defense against encapsulated bacteria (S. pneumoniae, H. influenzae type b, N. meningitidis). These organisms evade immune clearance without opsonization and splenic filtration. Post-splenectomy patients must be vaccinated against all three before surgery when possible, and the smear will show Howell-Jolly bodies (nuclear remnants normally removed by the spleen). Missing this complication is a common Step 1 error.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Identify the specific cytoskeletal proteins defective in HS (ankyrin, spectrin, band 3) and explain why their dysfunction causes spherocyte formation and extravascular hemolysis in the spleen.
  2. Interpret the lab pattern of HS on a clinical vignette: recognize normocytic anemia with elevated MCHC, spherocytes on smear, negative direct Coombs test, and understand what the osmotic fragility test and EMA binding assay confirm.
  3. Recognize the complications of HS — including aplastic crisis (parvovirus B19), pigmented gallstones, and splenomegaly — and understand both the benefit of splenectomy (corrects hemolysis) and its cost (lifelong susceptibility to encapsulated organisms requiring vaccination).

Can you avoid these mistakes?

A 16-year-old has jaundice, splenomegaly, and a family history of anemia. Labs show hemoglobin 9.5, MCV 88, MCHC 38, spherocytes on smear, negative direct Coombs. What is the diagnosis, what confirmatory test would you order, and what is the underlying protein defect?
A patient with known hereditary spherocytosis develops a sudden drop in hemoglobin to 5 g/dL with no reticulocytes. What organism caused this, what does it do to the marrow, and why are HS patients particularly vulnerable?
Two patients have spherocytes on peripheral smear. One has a positive direct Coombs test and one has a negative direct Coombs test. What is the most likely diagnosis in each, and what is the mechanistic reason for the Coombs result difference?
After splenectomy for hereditary spherocytosis, what happens to the hemolysis, the MCHC, and the patient's infection risk? Which three organisms must the patient be vaccinated against, and what finding will now appear on the peripheral smear?

Related topics

Hemolytic Anemia — Intravascular vs Extravascular Hematopoiesis and Lineage Differentiation RBC Physiology and Lifespan WBC Differential and Function Platelet Physiology and Primary Hemostasis

See how your Anki deck covers this topic.

Upload your deck for a free audit →